Literature DB >> 11724336

Metastatic colorectal cancer stimulates collagen synthesis by fibroblasts.

D Basso1, S Mazza, E Greco, C Belluco, G Roveroni, F Navaglia, D Nitti, M Lise, M Plebani.   

Abstract

BACKGROUND: We ascertained in vitro whether there were any differences in the growth of fibroblasts and the production of collagen (PIIIP), in relation to the presence of conditioning sera or tumor tissues from colorectal cancer (CRC) patients with disease progression or regression after surgery. PATIENTS AND METHODS: Fibroblasts were conditioned with: 1) 10% of control (n=20) or CRC patients' (n=57) sera; 2) 10% of tumor tissue homogenates obtained from CRC patients without (group A, n=6) or with (group B, n=5) liver metastases. After surgery, 29/57 patients (group 1) developed while 28/57 (group 2) did not develop a recurrent disease.
RESULTS: The ratio between cell growth and PIIIP production increases when fibroblasts were conditioned by group I (p<0.05), but not by controls or group 2 sera. Tumor homogenates from group B inhibited cell growth (p<0.001), while they induced PIIIP production (p<0.001) in comparison with results from group A.
CONCLUSION: CRC non-metastatic cancer cells induce mainly fibroblasts growth, while metastatic cells mainly induce collagen synthesis. This effect is probably caused by soluble mediators, which partly pass into the systemic circulation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11724336

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

Review 1.  [Ossification in lung metastases of primary colorectal adenocarcinomas].

Authors:  J Birzele; I Schmitz; K-M Müller
Journal:  Pathologe       Date:  2003-01-22       Impact factor: 1.011

2.  Metastatic breast cancer cells in lymph nodes increase nodal collagen density.

Authors:  Asif Rizwan; Camille Bulte; Anusha Kalaichelvan; Menglin Cheng; Balaji Krishnamachary; Zaver M Bhujwalla; Lu Jiang; Kristine Glunde
Journal:  Sci Rep       Date:  2015-05-07       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.